BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 30690341)

  • 1. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
    Yang X; Huang Q; Yang H; Liu S; Chen B; Liu T; Yang J; Yao H; Lin S; Chen X; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Apr; 29():94-99. PubMed ID: 30690341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.
    Hyun JW; Kim Y; Kim KH; Kim SH; Olesen MN; Asgari N; Siritho S; Paul F; Kim HJ
    J Neuroinflammation; 2022 Apr; 19(1):86. PubMed ID: 35413922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD.
    Kleerekooper I; Herbert MK; Kuiperij HB; Sato DK; Fujihara K; Callegaro D; Marignier R; Saiz A; Senel M; Tumani H; De Jong BA; Trip SA; Nakashima I; Verbeek MM; Petzold A
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):605-611. PubMed ID: 32217788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG
    Xiao J; Zhang SQ; Chen X; Tang Y; Chen M; Shang K; Deng G; Qin C; Tian DS
    Mult Scler Relat Disord; 2022 Oct; 66():104057. PubMed ID: 35870369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
    Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
    Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
    Schindler P; Aktas O; Ringelstein M; Wildemann B; Jarius S; Paul F; Ruprecht K
    Expert Rev Clin Immunol; 2023 Jan; 19(1):71-91. PubMed ID: 36378751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders.
    Wei Y; Chang H; Li X; Du L; Xu W; Cong H; Yao Y; Zhang X; Yin L
    Biomed Res Int; 2018; 2018():5381239. PubMed ID: 30426010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
    Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
    Akaishi T; Takahashi T; Misu T; Kaneko K; Takai Y; Nishiyama S; Ogawa R; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakashima I
    Neurology; 2021 Jul; 97(1):e1-e12. PubMed ID: 33980704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.
    Kim H; Lee EJ; Kim S; Choi LK; Kim K; Kim HW; Kim KK; Lim YM
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32184342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy.
    Ding J; Ren K; Wu J; Li H; Sun T; Yan Y; Guo J
    J Neurol; 2020 Sep; 267(9):2589-2593. PubMed ID: 32378036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
    Lucchinetti CF; Guo Y; Popescu BF; Fujihara K; Itoyama Y; Misu T
    Brain Pathol; 2014 Jan; 24(1):83-97. PubMed ID: 24345222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Slowly Progressive Myelitis and Longitudinally Extensive Spinal Cord Lesions.
    Kudo T; Kimura A; Higashida K; Yamada M; Hayashi Y; Shimohata T
    Intern Med; 2020 Nov; 59(21):2777-2781. PubMed ID: 32669494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Immunohistopathology in a Patient with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
    Shu Y; Long Y; Chang Y; Li R; Sun X; Wang Y; Huang Y; Li J; Chen J; Yang Y; Lu Z; Hu X; Kermode AG; Qiu W
    Neuroimmunomodulation; 2018; 25(1):1-6. PubMed ID: 29788018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
    Misu T; Takano R; Fujihara K; Takahashi T; Sato S; Itoyama Y
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):575-7. PubMed ID: 19372295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Area Postrema Syndrome-Like Symptoms without Medulla Oblongata Lesions.
    Iwami K; Nomura T; Seo S; Nojima S; Tsuzaka K; Kimura A; Shimohata T; Yabe I
    Neuroimmunomodulation; 2022; 29(4):433-438. PubMed ID: 35421859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.
    Shan F; Long Y; Qiu W
    Front Immunol; 2018; 9():2802. PubMed ID: 30568655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
    Ikeda K; Kiyota N; Kuroda H; Sato DK; Nishiyama S; Takahashi T; Misu T; Nakashima I; Fujihara K; Aoki M
    Mult Scler; 2015 Apr; 21(5):656-9. PubMed ID: 25257613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica.
    Takano R; Misu T; Takahashi T; Izumiyama M; Fujihara K; Itoyama Y
    Tohoku J Exp Med; 2008 May; 215(1):55-9. PubMed ID: 18509235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.